# Voyager Therapeutics, Inc.: Form 8-K, filed Feb 24, 2023

- Company: [Voyager Therapeutics, Inc.](/companies/vygr.md) (CIK 1640266)
- Form: 8-K
- Filed: 2023-02-24
- Accepted by EDGAR: Feb 24, 2023, 06:14 ET
- Period: 2023-02-21
- Accession: 0001104659-23-024939
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1640266/000110465923024939/tm237527d2_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1640266/000110465923024939/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1640266/000110465923024939/tm237527d2_8k.htm

Filed Feb 24, 2023.
Source: SEC EDGAR, the filing index for accession 0001104659-23-024939. Last ingested by Listed: Nov 5, 2026, 16:29 ET. No prices; not investment advice.
